Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thrombin Concentration Shapes Endothelial Extracellular Vesicle Profiles with Divergent Inflammatory Functions.

Blood advances·2026
Same author

Factor VIIa-released extracellular vesicles attenuate joint bleed-induced hemophilic arthropathy.

Blood·2025
Same author

Extracellular Vesicles Contribute to the Pathophysiology and Progression of Pleural Fibrosis by Promoting Mesothelial-to-Mesenchymal Transition and Neoangiogenesis.

American journal of respiratory cell and molecular biology·2025
Same author

CXC-Chemokine-Receptor-Type-5 Expression on Circulating Naive B Cells Predicts Improvement After Cardiac Resynchronization Therapy.

JACC. Basic to translational science·2025
Same author

Unstable Coronary Artery Plaque Features in Humans Are Associated with Higher Frequency of Circulating CD56bright Natural Killer Cells.

Journal of vascular research·2025
Same author

Coagulation protease-induced extracellular vesicles: their potential effects on coagulation and inflammation.

Journal of thrombosis and haemostasis : JTH·2024
Same journal

Compositional and Functional Metabolic Shifts in the Endometrial Microbiota of Cows (<i>Bos taurus</i>) During the Transition Period: A Metagenomic Next-Generation Sequencing Approach.

Frontiers in bioscience (Elite edition)·2026
Same journal

Insights Into the Characterization and Application of <i>Pseudomonas taetrolens</i>.

Frontiers in bioscience (Elite edition)·2026
Same journal

Small Helper Ti-plasmid Coexisting With the <i>A281virF</i> Gene Encoding an F-Box-Like Protein Improves the Efficiency of T-DNA Transfer From <i>Agrobacterium</i> Cells to Plant Cells.

Frontiers in bioscience (Elite edition)·2026
Same journal

AAV9-Mediated Targeting of Defined Neuronal Populations in Spinal Cord Through Intrathecal Injection.

Frontiers in bioscience (Elite edition)·2026
Same journal

Progress in Bioengineering: An Extensive Examination of State-of-the-Art Innovations in the Development of Artificial Corneas.

Frontiers in bioscience (Elite edition)·2026
Same journal

Nitrosylcobalamin Selectively Targets Tumors via Cobalamin Uptake and Lysosomal Processing.

Frontiers in bioscience (Elite edition)·2026
See all related articles

Related Experiment Video

Updated: May 26, 2026

Extracellular Vesicle Tissue Factor Activity Assay
03:53

Extracellular Vesicle Tissue Factor Activity Assay

Published on: December 29, 2023

Tissue factor: mechanisms of decryption.

L Vijaya Mohan Rao1, Hema Kothari, Usha R Pendurthi

  • 1Center for Biomedical Research, The University of Texas Health Science Center at Tyler, Tyler, Texas 75708, USA. vijay.rao@uthct.edu

Frontiers in Bioscience (Elite Edition)
|December 29, 2011
PubMed
Summary
This summary is machine-generated.

Tissue factor (TF) is mostly inactive until triggered by stimuli like phosphatidylserine (PS) exposure. This review explores TF decryption mechanisms and regulation, highlighting protein disulfide isomerase as a potential regulator.

More Related Videos

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets
10:08

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets

Published on: November 22, 2024

Tracking Fibrinolysis of Chandler Loop-Formed Whole Blood Clots Under Shear Flow in An In-Vitro Thrombolysis Model
06:16

Tracking Fibrinolysis of Chandler Loop-Formed Whole Blood Clots Under Shear Flow in An In-Vitro Thrombolysis Model

Published on: April 19, 2024

Related Experiment Videos

Last Updated: May 26, 2026

Extracellular Vesicle Tissue Factor Activity Assay
03:53

Extracellular Vesicle Tissue Factor Activity Assay

Published on: December 29, 2023

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets
10:08

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets

Published on: November 22, 2024

Tracking Fibrinolysis of Chandler Loop-Formed Whole Blood Clots Under Shear Flow in An In-Vitro Thrombolysis Model
06:16

Tracking Fibrinolysis of Chandler Loop-Formed Whole Blood Clots Under Shear Flow in An In-Vitro Thrombolysis Model

Published on: April 19, 2024

Area of Science:

  • Biochemistry
  • Cell Biology
  • Hematology

Background:

  • Tissue Factor (TF) is crucial in coagulation, but most exists in an inactive, cryptic state.
  • The mechanisms differentiating active from cryptic TF and TF decryption remain incompletely understood.
  • Phosphatidylserine (PS) exposure is a known inducer of TF decryption, but other factors may also be involved.

Purpose of the Study:

  • To critically review the literature on Tissue Factor (TF) encryption and decryption.
  • To emphasize recent findings and novel proposed mechanisms of TF decryption.
  • To provide expert perspective on the regulation of TF activity.

Main Methods:

  • Literature review of scientific articles on TF encryption/decryption.
  • Critical analysis of recent data and proposed regulatory mechanisms.
  • Synthesis of current knowledge and expert opinion.

Main Results:

  • A small fraction of cell surface Tissue Factor (TF) is active in coagulation; the majority is cryptic.
  • Phosphatidylserine (PS) exposure is a primary trigger for TF decryption.
  • TF self-association, membrane domain interactions, and protein disulfide isomerase (PDI) activity are potential regulators of TF decryption.

Conclusions:

  • TF decryption is a complex process influenced by multiple factors, including PS exposure and PDI.
  • Further validation is needed for proposed mechanisms, such as PDI's role in regulating TF decryption.
  • Understanding TF encryption/decryption is vital for controlling coagulation and related pathologies.